March 17, 2021
AI isn't ready for COVID-19 prime time. A systematic review of published this week in nature machine intelligence warns that new models using machine learning to review chest radiographs and chest computed tomographies for COVID-19 have major methodical deficiencies or underlying biases.
Among the 62 published or pre-print papers outlining these approaches, the authors wrote that not a single one...
October 23, 2020
PAINCHEK ANNOUNCES CARE HOME CAMPAIGN
Responding to the NHSX pledge to give 11,000 iPads to UK care homes, AI-powered pain assessment company, PainChek, has announced a one-off campaign to help UK care homes benefit from its technology.
PainChek is offering all UK care homes a one-off unique voucher of up to £500 to cover the cost of product training for their staff so they can use the PainChek...
September 22, 2020
Australia-based AI-powered pain assessment company, PainChek, is working to raise awareness of the importance of effective assessment of pain in people with dementia.
The AI technology company has published a new report called ‘Pain and dementia: common challenges for care managers’, which investigates the relationship between pain and dementia,
The report also examines how pain affects the...
February 9, 2020
According to a paper titled Pain Management in the Elderly Population: A Review published in The Ochsner Journal in 2010, pain may be underreported because some elderly patients incorrectly believe that pain is a normal process of aging. In addition, caregivers and relatives are often the most reliable source of information. However, assessing pain levels is usually not straightforward – it can...
October 17, 2019
Australia-based PainChek, developer of the world’s first smart phone-based pain assessment and monitoring app, announced that it will be partnering with Ward Medication Management (Ward MM) to deliver the federally funded national roll-out of PainChek technology to the Australian Residential Aged Care market. Ward MM is an Australian provider of medication review and quality use of medicines...
August 6, 2019
Hot on the heels on being granted a US patent for pain assessment invention last month, Australia-based PainChek, developer of the world’s first smart phone-based pain assessment and monitoring app, has received regulatory approval from Singapore’s Health Sciences Authority (HSA) for the use of the PainChek app in the market.
PainChek has also entered a two-year license agreement with Singapore-...
July 24, 2019
Australian digital health company PainChek recently announced that the United States Patent Office has issued a Notice of Allowance for its pain assessment invention. This means that patent prosecution has been successfully completed.
The U.S. patent, when granted, gives PainChek exclusive rights to exclude others from making, using, selling or importing the invention for 20 years from the...
May 3, 2019
The federal government of Australia recently announced that it will invest A$5M to facilitate the implementation of PainChek’s pain recognition app in Australian residential aged care centres (RAC’s).
The PainChek app was originally conceived at Western Australia’s Curtin University and further developed by listed Australian digital health company PainChek Ltd. It provides caregivers and health...